Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LRRK2 | Q5S007 | 17/20 | 0.61 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.42 |
| ▸ | IGF1R | P08069 | 1/20 | 0.39 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28439201 | 0.84 | LRRK2 (0.48) | LRRK2IGF1RCDK2KCNH2IRAK4 | |
| SCHEMBL5020932 | 0.78 | LRRK2 (0.59) | LRRK2MAP3K14 | |
| SCHEMBL5021144 | 0.78 | LRRK2 (0.59) | LRRK2IGF1RCDK2KCNH2 | |
| SCHEMBL5021351 | 0.76 | LRRK2 (0.75) | LRRK2 | |
| SCHEMBL20555455 | 0.76 | LRRK2 (1.00) | LRRK2 | |
| SCHEMBL9930430 | 0.76 | LRRK2 (0.56) | LRRK2MAP3K14 | |
| SCHEMBL5021248 | 0.76 | LRRK2 (0.56) | LRRK2MAP3K14 | |
| SCHEMBL22300155 | 0.75 | LRRK2 (0.57) | LRRK2IRAK4 | |
| SCHEMBL22300597 | 0.75 | LRRK2 (0.52) | LRRK2 | |
| SCHEMBL15528273 | 0.74 | LRRK2 (0.70) | LRRK2MAP3K14IRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111484482-B | Alkynyl pyrimidine or alkynyl pyridine compound, and composition and application thereof | 北京赛特明强医药科技有限公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-111484482-A | Alkynyl pyrimidine or alkynyl pyridine compound, and composition and application thereof | 北京赛特明强医药科技有限公司 | 2020-08-04 | — | — | CN | disclosed |